Structure Therapeutics Stock Forecast

Stock Price Forecast

The 12 analysts that cover Structure Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $103.17, which forecasts a 163.86% increase in the stock price over the next year. The lowest target is $65 and the highest is $140.

Price Target: $103.17 (+163.86%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$65	$103.17	$101	$140
Change	+66.24%	+163.86%	+158.31%	+258.06%

Analyst Ratings

The average analyst rating for Structure Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	7	7	7	7	8	8
Buy	4	5	5	4	4	4
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	11	12	12	11	12	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Edward Nash Canaccord Genuity	Canaccord Genuity	Strong Buy Initiates $101	Strong Buy	Initiates	$101	+158.31%	Apr 27, 2026
Ananda Ghosh HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $114 → $100	Strong Buy	Maintains	$114 → $100	+155.75%	Mar 16, 2026
Ananda Ghosh HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $90 → $114	Strong Buy	Maintains	$90 → $114	+191.56%	Mar 2, 2026
Jonathan Wolleben Citizens	Citizens	Buy Maintains $120 → $113	Buy	Maintains	$120 → $113	+189.00%	Feb 27, 2026
Hardik Parikh JP Morgan	JP Morgan	Buy Maintains $65 → $105	Buy	Maintains	$65 → $105	+168.54%	Jan 22, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

39.23K

EPS This Year

-1.75

from -2.39

EPS Next Year

-2.19

from -1.75

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	-	-	-	39.23K
Revenue Growth	-	-	-	-	-	-	-
EPS	-16.13	-16.54	-2.44	-2.33	-2.39	-1.75	-2.19
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	19	16

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	525,000
Avg	n/a	39,229
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-1.39	-1.61
Avg	-1.75	-2.19
Low	-2.19	-2.86

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.